We are live on ! Find out more
NSPR icon

InspireMD

16 hedge funds and large institutions have $137K invested in InspireMD in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.51% more ownership

Funds ownership: 1.36%1.87% (+0.51%)

0% more funds holding

Funds holding: 1616 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

19% less capital invested

Capital invested by funds: $169K → $137K (-$31.5K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
16
Holders Change
Holders Change %
0%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
2
Closed
3
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$5K

NSPR Hedge Fund Activity: Q4 2022 in Review

16 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q4 2022, worth a combined $137K — down 19% from $169K a quarter earlier.

Fund positioning in NSPR was balanced in Q4 2022: 3 funds opened new positions, 3 closed out, 0 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $42K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $23K sold.

  • 16 institutional investors held InspireMD (NSPR) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $137K of InspireMD stock for Q4 2022, down 19% quarter-over-quarter.
  • 3 funds opened new InspireMD positions in Q4 2022 and 3 closed out, a net change of 0 holders.
  • The largest InspireMD buyer in Q4 2022 was Citadel Advisors, an estimated $42K added.
  • The largest InspireMD seller in Q4 2022 was Susquehanna International Group, an estimated $23K sold.

Based on aggregated 13F filings for Q4 2022.